William J. Sandborn, See Remarks at Ventyx Biosciences, Inc. (VTYX), sold 5,465 shares at $36.09 ($199K) on 2023-05-15, disclosed to the SEC on 2023-05-16.
Open-market sale of $199k VTYX by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.09 | 1,978 | $71K | 35.9% |
| 2 | $36.09 | 1,978 | $71K | 35.9% |
| 3 | $36.88 | 1,309 | $48K | 24.3% |
| 4 | $37.66 | 200 | $8K | 3.8% |
| Total | $36.34 avg | 5,465 | $199K | 100% |
| Filing → |
| VTYX | SELL | 2023-08-01 | $884K | — | Filing → |
| VTYX | SELL | 2023-07-05 | $615K | — | Filing → |
| VTYX | SELL | 2023-06-27 | $706K | — | Filing → |